Abad-Esteve, A <br/><br/>
[VP-16, vincristine, adriamycin and cyclophosphamide (EVAC) in patients with small-cell lung cancer].  [electronic resource] 

 -  Medicina clinica  Apr 1988 
 - 569-72 p.  digital 
<br/><br/> Publication Type: Comparative Study; English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>0025-7753 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Small Cell--drug therapy<br/>Cyclophosphamide--adverse effects<br/>Doxorubicin--adverse effects<br/>Follow-Up Studies<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Podophyllotoxin--adverse effects<br/>Time Factors<br/>Vincristine--adverse effects